Funding for this research was provided by:
National Cancer Institute (CA196975)
Department of Radiology, Mayo Clinic
Received: 13 September 2017
Accepted: 16 October 2017
First Online: 27 October 2017
Ethics approval and consent to participate
: All participants provided informed consent. Approval of the study was obtained from the Mayo Clinic Institutional Review Board (no. 15-02494). All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Consent to publish was obtained from all participants.
: Dr. Stephen Russell owns stock and is founder of Vyriad. Dr. Russell owns stock and is co-founder of Imanis Life Sciences. Dr. Kah Whye Peng owns stock and is co-founder of Imanis Life Sciences. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.